 |
|
 |
 |

Home > Company Index > Drugs > Drug Manufacturers - Other > Bentley Pharmaceuticals, Inc.
 |
Bentley Pharmaceuticals, Inc. |
 |
 |
 |
NEWS FROM THE STANDARD |
 |
VW Snubs 'Big Three' Online Deal
Apr 12 2000 11:14 AM PDT
PROFILE |
 |
Bentley Pharmaceuticals makes sure that the drugs get delivered. The company develops drug-delivery systems at its research facility in the US; some 99% of the company's revenues, however, are generated by its Spanish subsidiaries, Laboratorios Belmac and Laboratorios Davur, which make and sell branded and generic pharmaceuticals, respectively. Their products target four therapeutic categories: cardiovascular, gastrointestinal, neurological, and infectious diseases. The company distributes its products in Spain and other European countries and has marketing agreements for the US with such firms as Merck and AstraZeneca; it also has a license to market some 75 drugs in Spain for Teva Pharmaceutical Industries.
COMPETITION |
 |
Elan Corporation, plc (ELN)
Medtronic, Inc. (MDT)
Schering-Plough Corporation (SGP)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 18.60
1-Yr. Sales Growth: (7.9)%
Employees: 209
Revenue per employee: $88,995.22
KEY PEOPLE |
 |
James R. Murphy
CEO
Michael D. Price
CFO
CONTACT INFO |
 |
65 Lafayette Rd., 3 Fl.
North Hampton, NH 03862
US
Phone: 603-964-8006
Fax: 603-964-6889
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |